Your browser doesn't support javascript.
loading
Occurrence and significance of Omicron BA.1 infection followed by BA.2 reinfection
Marc Stegger; Sofie Marie Edslev; Raphael Niklaus Sieber; Anna Cacilia Ingham; Kim Lee Ng; Man-Hung Eric Tang; Soren Alexandersen; Jannik Fonager; Rebecca Legarth; Magdalena Utko; Bartlomiej Wilkowski; Vithiagaran Gunalan; Marc Bennedbaek; Jonas Byberg-Grauholm; Camilla Holten Moeller; Lasse Engbo Christiansen; Christina Wiid Svarrer; Kirsten Ellegaard; Sharmin Baig; Thor Bech Johannesen; Laura Espenhain; Robert Skov; Arieh Sierra Cohen; Nicolai Balle Larsen; Karina Meden Soerensen; Emeily Dibba White; Troels Lillebaek; Henrik Ullum; Tyra Grove Krause; Anders Fomsgaard; Steen Ethelberg; Morten Rasmussen.
Afiliación
  • Marc Stegger; Statens Serum Institut
  • Sofie Marie Edslev; Statens Serum Institut
  • Raphael Niklaus Sieber; Statens Serum Institut
  • Anna Cacilia Ingham; Statens Serum Institut
  • Kim Lee Ng; Statens Serum Institut
  • Man-Hung Eric Tang; Statens Serum Institut
  • Soren Alexandersen; Statens Serum Institut
  • Jannik Fonager; Statens Serum Institut
  • Rebecca Legarth; Statens Serum Institut
  • Magdalena Utko; Statens Serum Institut
  • Bartlomiej Wilkowski; Statens Serum Institut
  • Vithiagaran Gunalan; Statens Serum Institut
  • Marc Bennedbaek; Statens Serum Institut
  • Jonas Byberg-Grauholm; Statens Serum Institut
  • Camilla Holten Moeller; Statens Serum Institut
  • Lasse Engbo Christiansen; Technical University of Denmark
  • Christina Wiid Svarrer; Statens Serum Institut
  • Kirsten Ellegaard; Statens Serum Institut
  • Sharmin Baig; Statens Serum Institut
  • Thor Bech Johannesen; Statens Serum Institut
  • Laura Espenhain; Statens Serum Institut
  • Robert Skov; Statens Serum Institut
  • Arieh Sierra Cohen; Statens Serum Institut
  • Nicolai Balle Larsen; Statens Serum Institut
  • Karina Meden Soerensen; Statens Serum Institut
  • Emeily Dibba White; Statens Serum Institut
  • Troels Lillebaek; Statens Serum Institut
  • Henrik Ullum; Statens Serum Institut
  • Tyra Grove Krause; Statens Serum Institut
  • Anders Fomsgaard; Statens Serum Institut
  • Steen Ethelberg; Statens Serum Institut
  • Morten Rasmussen; Statens Serum Institut
Preprint en Inglés | medRxiv | ID: ppmedrxiv-22271112
ABSTRACT
The newly found Omicron SARS-CoV-2 variant of concern has rapidly spread worldwide. Omicron carries numerous mutations in key regions and is associated with increased transmissibility and immune escape. The variant has recently been divided into four subvariants with substantial genomic differences, in particular between Omicron BA.1 and BA.2. With the surge of Omicron subvariants BA.1 and BA.2, a large number of reinfections from earlier cases has been observed, raising the question of whether BA.2 specifically can escape the natural immunity acquired shortly after a BA.1 infection. To investigate this, we selected a subset of samples from more than 1,8 million cases of infections in the period from November 22, 2021, until February 11, 2022. Here, individuals with two positive samples, more than 20 and less than 60 days apart, were selected. From a total of 187 reinfection cases, we identified 47 instances of BA.2 reinfections shortly after a BA.1 infection, mostly in young unvaccinated individuals with mild disease not resulting in hospitalization or death. In conclusion, we provide evidence that Omicron BA.2 reinfections do occur shortly after BA.1 infections but are rare.
Licencia
cc_by
Texto completo: Disponible Colección: Preprints Base de datos: medRxiv Idioma: Inglés Año: 2022 Tipo del documento: Preprint
Texto completo: Disponible Colección: Preprints Base de datos: medRxiv Idioma: Inglés Año: 2022 Tipo del documento: Preprint
...